Evotec SE Set to Reveal Fiscal Year 2023 Results on April 24, 2024

• Evotec SE will announce its financial results for the fiscal year 2023 on 24 April 2024.
• The company will hold a conference call to discuss the results and provide an update on its performance.
• The conference call will be held in English and the details will be available on the company's website.
• Evotec SE is a life science company with a unique business model and a multimodality platform for the discovery, development, and production of pharmaceutical products.
• The company operates globally with more than 5,000 highly qualified people and has strategic activities in a broad range of therapeutic areas.
• The announcement contains forward-looking statements concerning future events, including the proposed offering and listing of Evotec’s securities.

The next important date, Business report 2023 and webcast, at Evotec is on 24.04.2024.

The price of Evotec at the time of the news was 13,255EUR and was down -0,41 % compared with the previous day.
4 minutes after the article was published, the price was 13,300EUR this corresponds to a plus of +0,34 % since publication.
At this time, the index MDAX was at 26.037,78PKT (+0,17 %).

Evotec

+1,50 %

-28,31 %

-33,06 %

-31,44 %

-41,05 %

-70,63 %

-55,39 %

+177,31 %

+294,58 %

ISIN:DE0005664809WKN:566480

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max